Hypertension and Vascular Disorders

  • Pathophysiology and Risk Factors
  • Hypertension and Target Organ Damage
  • Vascular Disorders and Endothelial Dysfunction
  • Resistant Hypertension and Secondary Hypertension
  • Hypertension in Special Populations

Hypertension and vascular disease remain among the most modifiable drivers of cardiovascular morbidity; the Hypertension and Vascular Disorders session focuses on the pathogenesis, advanced diagnostics and multi-level management strategies for blood pressure–related vascular injury. Attendees will evaluate evidence across primary care, specialty clinics and population programs that link blood pressure control with reduced stroke, heart failure and renal outcomes. The session highlights innovative approaches to resistant hypertension, device-based therapies, and precision antihypertensive regimens tailored by phenotype and comorbidity. Practical workshops will demonstrate protocols for ambulatory and home blood pressure monitoring, integration of vascular imaging for target-organ assessment, and multidisciplinary approaches that incorporate lifestyle medicine, pharmacotherapy optimization and population screening. Speakers will cover the role of arterial stiffness, endothelial dysfunction and microvascular disease in driving end-organ damage, and present translational research on novel vasoactive targets. Join peers to compare implementation strategies—from guideline adoption to community outreach—and to plan collaborative pathways that scale high-impact hypertensive care. Plenary discussions will link these themes to the broader Hypertension Conference program and to clinical priorities such as blood pressure management across diverse settings.

Clinical Priorities & Program Highlights

Diagnosis and monitoring best practices

  • Role of ambulatory monitoring and home BP measurement
  • Standardizing protocols for cuff selection and measurement frequency

Pharmacologic strategies and personalization

  • Combination therapy and sequential drug initiation
  • Tailoring regimens to comorbidities and organ protection

Device and interventional options

  • Baroreceptor modulation and renal denervation evidence
  • Patient selection and safety considerations

Vascular consequences and organ protection

  • Managing arterial stiffness and microvascular disease
  • Strategies to protect renal and cerebrovascular function

Practice & Policy Impact

Lower population risk
Adopt screening and public health measures that reduce hypertension prevalence.

Reduce complications
Implement evidence-based protocols to lower stroke, HF and CKD incidence.

Optimize care delivery
Use task-shifting, telemonitoring and integrated care for improved BP control.

Inform guideline updates
Translate trial evidence into practical recommendations for clinicians.

Related Sessions You May Like

Join the Global Cardiology & Cardiovascular Science Community

Join leading cardiologists, cardiovascular scientists, and healthcare experts from around the world. Present your pioneering research and explore the latest breakthroughs in heart health, cardiovascular diseases, and cutting-edge treatments driving the future of cardiology.

Copyright 2024 Mathews International LLC All Rights Reserved

Watsapp
Top